New device aims to simplify prostate cancer diagnosis

NCT ID NCT05362032

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 24 times

Summary

This study tests whether a new device called the OmnEcoil system can safely and effectively combine two separate procedures—MRI imaging and biopsy—into one session for diagnosing prostate cancer. The device uses a special coil placed in the rectum to take high-quality images and guide the biopsy at the same time. The trial involves 45 men aged 45 and older with elevated PSA levels or abnormal exams, and it will check if the device can successfully collect tissue samples without causing serious side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • OHSU Knight Cancer Institute

    Portland, Oregon, 97239, United States

Conditions

Explore the condition pages connected to this study.